Generics-Regulatory Impact on Marketing
FDA Proposes New, Tougher Procedures for Membership on Advisory Committees
...more stringent approach for considering potential conflicts of interest for its advisory committee members and for recommending eligibility ...
Date:
03/21/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01591.html
FDA probing safety of children's cold medicines
Over-the-counter remedies haven't been tested enough, newspaper reports
Date:
03/02/2007
, Publication:
MSNBC
, Author:
Associated Press
http://www.msnbc.msn.com/id/17417416/
MEDICAID CUTS WOULD CHILL GENERIC DISPENSING
Instead of encouraging community pharmacists to help control health costs by dispensing lower-priced generic drugs, the Bush Administration's new reimbursement plan for Medicaid pharmacies will do just the opposite...
Date:
02/01/2007
, Publication:
Pharmacy Times
, Author:
Pharmacy Times
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4398
STATES PRESSURE FDA FOR GENERIC INSULIN
Mississippi Gov Haley Barbour is leading a group of officials from 11 states in a drive to secure marketing approval for a cost-saving generic version of insulin
Date:
02/01/2007
, Publication:
Pharmacy Times
, Author:
Pharmacy Times
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4403
SUPREME COURT HANDS VICTORY TO GENERICS
...the Supreme Court struck down a key strategy used by branded pharmaceutical manufacturers to delay competition from lower-cost generics...
Date:
02/01/2007
, Publication:
Pharmacy Times
, Author:
Pharmacy Times
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4396
Medicare Part D sees flurry of late changes
According to a recent survey from the Kaiser Family Foundation and the Harvard School of Public Health, only...
Date:
01/22/2007
, Publication:
Drug Topics
, Author:
Reid Paul
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=398008
GENERIC WARFARIN A SAFE SUBSTITUTE
A new analysis suggests that substitution of generic warfarin for brand-name warfarin (Coumadin, Bristol-Myers Squibb) has no appreciable effect...
Date:
01/01/2007
, Publication:
Pharmacy Times
, Author:
Anna D. Garrett, PharmD, BCPS, CPP
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4288
FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers
...regarding the potential for stomach bleeding and liver damage and when to consult a doctor...
Date:
12/19/2006
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01533.html
DEA proposes easing restrictions on Schedule II drugs
The policy statement reiterates DEA's commitment to striking the proper balance
Date:
10/23/2006
, Publication:
Drug Topics
, Author:
Reid Paul
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=379883
Pharmacies prepare for fraud and abuse audits
clear polices to avoid being investigated or prosecuted for fraud and abuse related to Medicare...
Date:
10/09/2006
, Publication:
Drug Topics
, Author:
Catherine MacRae Hockmuth
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=376032
< Previous
Page 3 of 21
Next >
Search returned 203 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|